FOXAI: a phase II trial evaluating the efficacy and safety of hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin for advanced hepatocellular carcinoma

被引：118
|
作者：
Lyu, Ning [1 ]
Lin, Youen [2 ]
Kong, Yanan [3 ]
Zhang, Zhenfeng [1 ]
Liu, Longzhong [1 ]
Zheng, Lie [1 ]
Mu, Luwen [1 ]
Wang, Jianpeng [4 ]
Li, Xishan [5 ]
Pan, Tao [1 ]
Xie, Qiankun [1 ]
Liu, Yaru [1 ]
Lin, Aihua [6 ]
Wu, Peihong [1 ]
Zhao, Ming [1 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Div Minimally Invas Intervent, Dept Med Imaging & Intervent Radiol, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Intervent Radiol, Jieyang Affiliated Hosp, Jieyang, Peoples R China
[3] Sun Yat Sen Univ, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Dept Minimally Invas Intervent & Target Treatment, Affiliated Foshan Hosp, Foshan, Peoples R China
[5] First Peoples Hosp, Dept Intervent Radiol, Guangzhou, Guangdong, Peoples R China
[6] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China
来源：
GUT | 2018年 / 67卷 / 02期
关键词：
SORAFENIB; CHEMOTHERAPY;
D O I：
10.1136/gutjnl-2017-314138
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：395 / U258
页数：3
相关论文
共 50 条
  • [21] Sorafenib plus hepatic arterial infusion of oxaliplatin and fluorouracil vs sorafenib plus transarterial chemoembolization for advanced hepatocellular carcinoma: A biomolecular exploratory, randomized, phase III trial (SHATA-001).
    Lai, Zhicheng
    Kan, Anna
    He, Minke
    Du, Zefeng
    Shi, Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Hepatic arterial infusion chemotherapy (HAIC) with oxaliplatin, fluorouracil, and leucovorin (FOLFOX) versus transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (HCC): A randomised phase III trial
    Shi, M.
    Li, Q.
    He, M.
    Guo, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S688 - S688
  • [23] Phase II Study of Sorafenib Combined with Concurrent Hepatic Arterial Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin for Unresectable Hepatocellular Carcinoma with Major Portal Vein Thrombosis
    Min-Ke He
    Ru-Hai Zou
    Qi-Jiong Li
    Zhong-Guo Zhou
    Jing-Xian Shen
    Yong-Fa Zhang
    Zi-Shan Yu
    Li Xu
    Ming Shi
    CardioVascular and Interventional Radiology, 2018, 41 : 734 - 743
  • [24] Phase II Study of Sorafenib Combined with Concurrent Hepatic Arterial Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin for Unresectable Hepatocellular Carcinoma with Major Portal Vein Thrombosis
    He, Min-Ke
    Zou, Ru-Hai
    Li, Qi-Jiong
    Zhou, Zhong-Guo
    Shen, Jing-Xian
    Zhang, Yong-Fa
    Yu, Zi-Shan
    Xu, Li
    Shi, Ming
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 41 (05) : 734 - 743
  • [25] Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial
    Ikeda, M.
    Shimizu, S.
    Sato, T.
    Morimoto, M.
    Kojima, Y.
    Inaba, Y.
    Hagihara, A.
    Kudo, M.
    Nakamori, S.
    Kaneko, S.
    Sugimoto, R.
    Tahara, T.
    Ohmura, T.
    Yasui, K.
    Sato, K.
    Ishii, H.
    Furuse, J.
    Okusaka, T.
    ANNALS OF ONCOLOGY, 2016, 27 (11) : 2090 - 2096
  • [26] Phase II trial of hepatic arterial infusion chemotherapy using cisplatin and 5-fluorouracil in patients with advanced hepatocellular carcinoma.
    Tanaka, M
    Ando, E
    Yutani, S
    Yamashita, F
    Fukumori, K
    Kuromatsu, R
    Shimauchi, Y
    Itano, S
    Nagamtsu, H
    Matsugaki, S
    Ono, N
    Sakisaka, S
    HEPATOLOGY, 1999, 30 (04) : 678A - 678A
  • [27] Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma
    Yang Zhao
    Jia Ying Lai
    Run Bin Liang
    Min Ke He
    Ming Shi
    Journal of Interventional Medicine, 2019, 2 (02) : 78 - 83
  • [28] Evaluation of Antiemetic Therapy for Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin
    Zhao, Yang
    He, MinKe
    Liang, RunBin
    Li, QiJiong
    Shi, Ming
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2021, 17 : 73 - 77
  • [29] Randomized, phase II study comparing interferon combined 5-fluorouracil plus cisplatin hepatic arterial infusion with interferon combined 5-fluorouracil hepatic arterial infusion in patients with advanced hepatocellular carcinoma
    Yamashita, T.
    Arai, K.
    Sunagozaka, H.
    Ueda, T.
    Terashima, T.
    Mizukoshi, E.
    Sakai, A.
    Nakamoto, Y.
    Honda, M.
    Kaneko, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] Efficacy of hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma
    Yang Hyun Baek
    Kyoung Tae Kim
    Sung Wook Lee
    Jin Sook Jeong
    Byeong Ho Park
    Kyung Jin Nam
    Jin Han Cho
    Young Hoon Kim
    Young Hoon Roh
    Hyung Sik Lee
    Young Min Choi
    Sang Young Han
    World Journal of Gastroenterology, 2012, (26) : 3426 - 3434
12345